Price T Rowe Associates Inc Point Biopharma Global Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.67 - $9.71 $63,751 - $92,808	9,558 Added 35.44%	36,531 $244,000
Q2 2023 Aug 14, 2023	SELL	$6.86 - $10.86 $67,365 - $106,645	-9,820 Reduced 26.69%	26,973 $245,000
Q1 2023 May 15, 2023	SELL	$6.78 - $8.1 $15,336 - $18,322	-2,262 Reduced 5.79%	36,793 $268,000
Q4 2022 Feb 14, 2023	SELL	$5.72 - $9.78 $62,462 - $106,797	-10,920 Reduced 21.85%	39,055 $285,000
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $361,819 - $515,242	49,975 New	49,975 $387,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.